Deciphering the mechanism of the dual functional E3 ligase TRIM28 in cancer cell...
Deciphering the mechanism of the dual functional E3 ligase TRIM28 in cancer cells
TRIM family proteins are RING-type E3 ubiquitin ligases with important roles in immune responses, autophagy and cellular signalling. They are characterised by the presence of an N-terminal tripartite motif that harbours the cataly...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
TRIM
Structure Function Studies of the TRIM Family of Ubiquitin E...
100K€
Cerrado
EMCOP9CRL
Structural basis of Cullin RING ligase regulation by the COP...
183K€
Cerrado
NEDD8ANDCRLLIGASES
Regulation and Function of Cullin Ring E3 ubiquitin ligases...
1M€
Cerrado
BFU2008-02795
ESTUDIO ESTRUCTURAL DE LOS CAMBIOS CONFORMACIONALES EN LAS U...
127K€
Cerrado
DDRDegronDiscovery
Substrate Selectivity in the Ubiquitin Dependent Response to...
207K€
Cerrado
CsnCRL
The molecular basis of CULLIN E3 ligase regulation by the CO...
2M€
Cerrado
Información proyecto TRIM MAGE complexes
Duración del proyecto: 24 meses
Fecha Inicio: 2021-03-17
Fecha Fin: 2023-03-31
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
TRIM family proteins are RING-type E3 ubiquitin ligases with important roles in immune responses, autophagy and cellular signalling. They are characterised by the presence of an N-terminal tripartite motif that harbours the catalytic RING domain and a C-terminal variable substrate-binding domain. TRIM28/KAP1 is a unique family member that is better known for its role in transcriptional repression, which is mediated via its C-terminal PHD-Bromo domains. Nevertheless, ubiquitination activity has been described for TRIM28, especially in cancer cells, in conjunction with Melanoma Antigen (MAGE) proteins. MAGE proteins are aberrantly expressed in many cancer types and have been proposed to regulate and activate TRIM28 E3 activity to mediate proteasomal degradation of prominent targets, including p53 and AMPK. Cellular and molecular details of TRIM28 MAGE-dependent ligase activity remain unknown. Furthermore, it is unclear, how the interplay between the two functions of TRIM28 is regulated and how the protein E3 ligase activity is supressed when recruited as part of transcriptional silencing complexes.
I want to use a multi-disciplinary approach and combine unbiased proteomic studies with in vitro biochemical, biophysical and structural experiments to study MAGE-dependent regulation of TRIM28 E3 ligase activity. I aim to identify cellular signals such as posttranslational modifications and interaction partners that can both modulate MAGE-TRIM28 complexes and regulate the interplay between the transcriptional and the E3 ligase activity. By combining these findings with structural and mechanistic studies, I will uncover how MAGE proteins modulate substrate recognition, E2 recruitment and ligase activity of TRIM28, and create a model of MAGE-TRIM28 function.